Ika-Werke
Drug Processing Technology and Laboratory Equipment
The National Institutes of Health (NIH), as well as the US Food and Drug Administration (FDA) and several medical bioresearchers, are developing standardised Covid-19 severity terminology and clinical trial templates to address biomarkers used in present clinical trials.
The workforce, ACTIV, is attempting to reach an agreement and issue recommendations as quickly as possible. Read more here.
Drug Processing Technology and Laboratory Equipment
Biopharmaceutical and Drug Development
Cloud-Based Off-the-Shelf Clinical Metadata Repository and Clinical Trial Automation Software Platform